Hospital Clínic de Barcelona

HCB is a university hospital ranked the best hospital in Spain and 63rd worldwide according to Newsweek, with 4,500 professionals covering most of medical specialties. HCB is placed in a top position in the areas of research and innovation (e.g. top participant in Societal Challenge 1-Health in H2020 in Spain), contributing highly to the research and innovation ecosystem in Catalonia, Spain and Europe.

Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) primary aim is to perform, promote, manage and disseminate, research and innovation within the field of biomedical science, focussing in particular on basic, translational and clinical research within the Hospital Clínic de Barcelona (HCB) (

FRCB-IBIBAPS and HCB are integrated within the Campus Clínic, a reference campus in healthcare, research and teaching activities with the aim of achieving excellence.

FRCB-IDIBAPS is also dedicated to translational research in the field of biomedicine with the mission of integrating the state of the art basic research and quality clinical research. The institution ranks first in scientific productivity and quality among the Certified Health Research Institutes of Spain (e.g. 1,815 indexed original articles and mean impact factor of 7.7 in 2021). Its mission is to combine clinical research of proven quality with high-level basic research.

In order accomplish this mission the researchers have novel and first-class infrastructures available together with six own core facilities offering a wide range of services under strict quality management controls performed at all levels. The institution has also a strong track record working in European projects (e.g. 90 projects obtained along H2020 and 22 in Horizon Europe) and has a dedicated European Projects Office (OPE) and the Knowledge and Technology Transfer Office (KTT).

Role of institution in the project

HCB is involved in WP2 (Engagement and Liaison of Data Providers), WP5 (Service and Data Interoperability Standardisation and Quality Framework) and WP7 (Use cases for platform expansion and validation).

Antonio López-Rueda

Antonio López-Rueda is project manager coordinator in HCB.

Luis Donoso

Luis Donoso is senior expert/advisor/researcher in HCB.

Salvador Pedraza

Salvador Pedraza is senior expert/advisor/researcher in HCB.

Xavier Pastor

Xavier Pastor is senior expert/advisor/researcher in HCB.

Santiago Frid

Santiago Frid is junior expert/advisor/researcher in HCB.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

March 14, 10:00-11:30 aM CET



Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.